Metraipolis › archive › dc_dce77805677d
Engineered fibroblast growth factor 1 variants uncouple glucose-lowering effects from mitogenic activity with therapeutic potential for type 2 diabetes — Europe PMC PMID:41520078
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41520078
- DOI
- 10.1186/s43556-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T22:10:09.579Z
- SHA-256 of the archived text
06c530151cf4558dad0469033fdf6d3e741acf89dabe625df7788b189d8c3541- Stable URL of this page
https://metraipolis.com/documento/dc_dce77805677d
How to cite
Engineered fibroblast growth factor 1 variants uncouple glucose-lowering effects from mitogenic activity with therapeutic potential for type 2 diabetes — Europe PMC PMID:41520078 — Europe PMC (en), https://europepmc.org/article/MED/41520078 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dce77805677d (Metraipolis archive dc_dce77805677d, sha256 06c530151cf4558dad0469033fdf6d3e741acf89dabe625df7788b189d8c3541)
BibTeX
@misc{dcdce77805677d,
title = {Engineered fibroblast growth factor 1 variants uncouple glucose-lowering effects from mitogenic activity with therapeutic potential for type 2 diabetes — Europe PMC PMID:41520078},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41520078},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dce77805677d; sha256 06c530151cf4558dad0469033fdf6d3e741acf89dabe625df7788b189d8c3541},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41520078. Agents can read the archived copy with the MCP tool read_document.